Cardiac Management Solutions Home ZOLL LifeVest: A Proven Therapy for Patients at Risk of Sudden Cardiac Death Patients Medical Professionals Careers ZOLL LifeVest: Providing Peace of Mind and Lifesaving Therapy The LifeVest®wearable cardioverter defibrillator (WCD) is designed to protect patients at...
Conclusions: A WCD is an effective therapy for prevention of sudden cardiac death during the recovery period of heart function after cardiac surgery. This is treatment with high patient compliance.Vusal HajiyevTemirlan ErkenovAndreas SmechowskiSoeren JustOliver GrimmigDirk Fritzsche心血管外科国际期刊(...
The ZOLL LifeVest WCD is prescribed by physicians for patients at risk of sudden cardiac death. Please seek your doctor’s advice before making any medical decisions. What’s New Aug 21, 2023 Version 1.1.0 Bug fixes and improvements.
The Risk of Sudden Cardiac Death Sudden cardiac arrest, often referred to as SCA, occurs when the heart’s electrical system malfunctions, causing the regulated heartbeat to become uncontrolled. When this system ceases to function properly, the heartbeat can spike immediately, causing the heart to...
LifeVest® is the most used, studied, and proven wearable defibrillator that has been worn by more than one million patients at risk of sudden cardiac death.
Although the patients included in Zishiri's study are a hodgepodge of patients with different risk factors for sudden cardiac death, the previous literature in this area does not support the hypothesis that a WCD would alter mortality in several of the subsets included. Although both an ICD and...
Varied statistics and studies have indicated that nearly 20 percent of DiGeorge syndrome patients tend to die during the first 12 months after birth. Most deaths occur due to cardiac problems and sepsis, the latter of which occurs due to severe immunodeficiency and subsequent bacterial or fungal ...
Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry) Circulation (2015) S.G. Priori et al. 2015 ESC Guidelines for the management of patients with ventricular arr...
We report the case of a 50 year-old woman referred for extraction of an infected biventricular implantable cardioverter defibrillator (ICD) who underwen... Antonio,Dello,Russo,... - 《Journal of Interventional Cardiac Electrophysiology》 被引量: 28发表: 2009年 Lead extraction: a new effective ...
In obesity and diabetes loss of metabolic flexibility is associated with impaired glucose oxidation and concomitant cardiac hypertrophy and dysfunc- tion [55]. Thus, strategies aiming to restore the resilience between energy substrates are warranted to maintain the ATP production in HFpEF [56]. A ...